COMMUNIQUÉS West-GlobeNewswire

Anavex Life Sciences to Present at the Noble Capital Markets 14th Annual Institutional Investor Conference

24/01/2018 - 13:00

NEW YORK, Jan. 24, 2018 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL ), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of [...]

Stemline Therapeutics Prices $51.8 Million Public Offering of Common Stock

24/01/2018 - 13:00

NEW YORK, Jan. 24, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML ), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, today announced the pricing of an underwritten [...]

The Joint Commission, American Heart Association/American Stroke Association Announce New Thrombectomy Certification

24/01/2018 - 13:00

OAKBROOK TERRACE, Ill., Jan. 24, 2018 (GLOBE NEWSWIRE) -- The Joint Commission, in collaboration with the American Heart Association/American Stroke Association, the world’s leading voluntary health organization devoted [...]

Cyclacel Pharmaceuticals to Present at the Noble Capital Markets Investor Conference

24/01/2018 - 13:00

BERKELEY HEIGHTS, N.J., Jan. 24, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC ) (NASDAQ: CYCCP ) (Cyclacel or the Company), a clinical-stage biopharmaceutical company using cell cycle, [...]

ChromaDex to Present at the 3rd Annual NAD+ Summit

24/01/2018 - 12:30

IRVINE, Calif., Jan. 24, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ: CDXC ), an integrated, science-based, nutraceutical company devoted to improving the way people age, announced today it will sponsor a gathering [...]

FDA Grants Approval to Shire for Technology Transfer of CINRYZE® Drug Product Manufacturing Process to Vienna, Austria Manufacturing Site

24/01/2018 - 12:01

FDA Grants Approval to Shire for Technology Transfer of CINRYZE® (C1 esterase inhibitor [human]) Drug Product Manufacturing Process to Vienna, Austria Manufacturing Site Second production source for Cinryze drug product [...]

Green Cures & Botanical Distribution, Inc. Appoints Three Experts to Advisory Board to Focus on Cryptocurrency and Business Development

24/01/2018 - 11:30

LOS ANGELES, CA, Jan. 24, 2018 (GLOBE NEWSWIRE) -- Green Cures and Botanical Distribution, Inc. (OTC PINK: GRCU), an innovative hemp-infused nutrition, botanical, sports, and body care products company, welcomes three [...]

Publishing of Orion Corporation's Financial Statement Release for 2017 on 7 February 2018

24/01/2018 - 10:46

ORION CORPORATION PRESS RELEASE 24 JANUARY 2018 at 11.45 A.M. EET Publishing of Orion Corporation's Financial Statement Release for 2017 on 7 February 2018 Orion will publish its Financial Statement Release for 2017 on [...]

Novartis delivered good operational performance and landmark innovation in 2017, entering our next growth phase

24/01/2018 - 07:01

Full year sales grew 2% (cc, +1% USD) as strong performance of our growth drivers, including Cosentyx and Entresto , more than offset Gleevec/Glivec generic erosion: Cosentyx grew to USD 2.1 billion in 2017, USD 615 [...]

Novartis a enregistré, en 2017, une belle performance opérationnelle et des innovations majeures, entrant ainsi dans une nouvelle phase de croissance

24/01/2018 - 07:01

Hausse de 2% (tcc, +1% USD) des ventes sur l'exercice complet, car l'excellente performance de nos moteurs de croissance, notamment Cosentyx et Entresto , a plus que compensé l'érosion due aux génériques de Gleevec/ [...]

ABLYNX APPOINTS DR ROBERT FRIESEN AS CHIEF SCIENTIFIC OFFICER

24/01/2018 - 07:01

GHENT, Belgium, 24 January 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced the appointment of Robert Friesen, PhD, as Chief Scientific Officer (CSO), effective 1 March 2018. Dr Friesen will lead the [...]

Insmed Announces Pricing of Public Offering of Convertible Senior Notes

24/01/2018 - 04:49

BRIDGEWATER, N.J., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq: INSM ) announced today that it priced its registered underwritten public offering of $400 million aggregate principal amount of its 1.75 [...]

Ultragenyx Announces Pricing of Public Offering of Common Stock

24/01/2018 - 03:40

NOVATO, Calif., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today [...]

Adamas Announces Pricing of Public Offering of Common Stock

24/01/2018 - 02:29

EMERYVILLE, Calif., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today announced the pricing of its underwritten public offering of 3,000,000 shares of its common stock at a price to [...]

Radient Technologies Inc. Announces Shares for Services Issuance

24/01/2018 - 01:00

EDMONTON, Alberta, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Corporation”) (TSX Venture:RTI) announces that the Corporation has issued an aggregate of 28,024 common shares to third [...]

HealthEquity to Announce Year-End HSAs and Custodial Assets

24/01/2018 - 00:06

DRAPER, Utah, Jan. 23, 2018 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY ) (“HealthEquity” or the “Company”), the nation’s largest health savings account (“HSA”) non-bank custodian, today announced that it plans [...]

National Research Corporation Chief Executive Officer Continues Estate Plan

24/01/2018 - 00:00

Lincoln, Nebraska, Jan. 23, 2018 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ: NRCIA and NRCIB) today announced that over the next few weeks, CEO Michael D. Hays will be gifting and/or transferring his [...]

Sanofi: Availability of the Pre-quarterly Results Communication

23/01/2018 - 22:31

Availability of the Pre-quarterly Results Communication Paris, France - January 23, 2018 - Sanofi announced today that its Pre-Quarterly Results Communication document is available on the "Investors" page of the company [...]

Sanofi : Mise en ligne du document «Pre-quarterly Results Communication »

23/01/2018 - 22:31

Mise en ligne du document «Pre-quarterly Results Communication » Paris, France - Le 23 janvier 2018 - Sanofi annonce la mise en ligne sur l'espace Investisseurs du site internet de la société, d'un document intitulé « [...]